CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ose Immunotherapeutics SA Company Snapshot
Ose Immunotherapeutics SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ose Immunotherapeutics SA with three other companies in this sector in France: Genoway (2018 sales of 10.81 million Euro [US$12.17 million] ), Cellectis SA (18.19 million Euro [US$20.48 million] of which 98% was Therapeutics), and Oncodesign Sa (20.06 million Euro [US$22.59 million] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ose Immunotherapeutics SA
  Stock Performance Chart for Ose Immunotherapeutics SA
 
  Stock Data: Recent Stock Performance:
  Current Price (4/18/2019): 4.05
(Figures in Euro)
1 Week -1.5%   13 Weeks 0.0%  
4 Weeks 11.0%   52 Weeks -6.5%  
 
Ose Immunotherapeutics SA Key Data:
  Ticker: OSE Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 24,456,000
(Year Ending Jan 2019).
Employees: 29
  Currency: Euro Market Cap: 59,341,446
  Fiscal Yr Ends: December Shares Outstanding: 14,652,209
  Share Type: Actions Ordinaires Closely Held Shares: 7,196,596
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.